Precision Treatment: Exploiting Recent Advances – Fast and Furious?
Event 2018 - Speakers & Topics
Jeffrey S. Weber, Professor, Deputy Director and Co-Director, Melanoma Program, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, USA
Cancer Immunotherapy – The Journey So Far and Where We are Heading
Laure Bindels, Louvain Drug Research Institute, Université catholique de Louvain, Belgium
The Microbiome, Cancer and Cachexia
Hege G. Russnes, Senior Consultant and Researcher, Oslo University Hospital, Norwegian Radium Hospital, Norway Anne Hansen Ree, Professor, Akershus University Hospital, University of Oslo, Norway
From Feasibility to Utility in Precision Cancer Medicine – Experiences from the First Norwegian Study of NGS-Based Therapy Decisions in Advanced Cancer
Douglas A. Levine, Professor, Director of Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center & Head, Gynecology Research Laboratory, NYU Langone Medical Center, New York, USA
Precision Medicine for Gynecologic Cancers – Opportunities and Obstacles
Andreas Engert, Professor for Internal Medicine, Hematology and Oncology, University Hospital of Cologne, Germany
Roadmap for European Hematology Research and Hodgkin Lymphoma: (Immuno)therapy, Late Effects and the Way Forward
Marcela V. Maus, Assistant Professor, Harvard Medical School & Director of Cellular Immunotherapy, Cancer Center, Massachusetts General Hospital, Boston, USA
The Next Generation of Engineered T-cells for Immunotherapy of Hematological and Solid Tumors
Marc Vaudel, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital and KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway Elisabeth Wik, Centre for Cancer Biomarkers, University of Bergen and Deparment of Pathology, Haukeland University Hospital, Norway
Making Sense of Big Data for Oncology Patients – Vision and Reality